The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation

International Journal of Oncology

Volumn 37, Issue 4, 2010, Pages 821-828

  Mukubou, Hideyo ^a   Tsujimura, Toshiaki ^a   Sasaki, Ryohei ^a   Ku, Yonson ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Autophagy; Gemcitabine; Pancreatic cancer; Radiation

Indexed keywords

3 METHYLADENINE; BECLIN 1; GEMCITABINE; PROTEIN; PROTEIN LIGHT CHAIN 3 II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IONIZING RADIATION; LIGHT CHAIN; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; UPREGULATION;

EID: 77956524618     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000732     Document Type: Article

References (25)

1. Huguet F, Andre T, Hammel P, et al: Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25: 326-331, 2007.
2. Okusaka T, Ito Y, Ueno H, et al: Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. Br J Cancer 91: 673-677, 2004. (Pubitemid 39141622)
3. Crane CH, Varadhachary G, Wolff RA, Pisters PW and Evans DB: The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. Best Pract Res Clin Gastroenterol 20: 365-382, 2006.
4. Gordon AT and McMillan TJ: A role for molecular radiobiology in radiotherapy? Clin Oncol 9: 70-78, 1997.
5. Blackstock AW, Bernard SA, Richards F, et al: Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 17: 2208-2212, 1999.
6. Rejiba S, Wack S, Aprahamian M and Hajri A: K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. Cancer Sci 98: 1128-1136, 2007.
7. Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000.
8. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004. (Pubitemid 38456176)
9. Klionsky DJ: Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8: 931-937, 2007.
10. Tan ML, Ooi JP, Ismail N, Moad AI and Muhammad TS: Programmed cell death pathways and current antitumor targets. Pharm Res 26: 1547-1560, 2009.
11. Lawrence TS, Davis MA, Hough A and Rehemtulla A: The role of apoptosis in 2'2'-diflouro-2'-deoxycytidine (gemcitabine)- mediated radiosensitization. Clin Cancer Res 7: 314-319, 2001.
12. Cao C, Subhawong T, Albert JM, et al: Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 66: 10040-10047, 2006.
13. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
14. Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5: 726-734, 2005. (Pubitemid 41486365)
15. Yang YP, Liang ZQ, Gao B, Jia YL and Qin ZH: Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol Sin 29: 123-134, 2008.
16. Ogier-Denis E and Codogno P: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603: 113-128, 2003.
17. Karantza-Wadsworth V and White E: Role of autophagy in breast cancer. Autophagy 3: 610-613, 2007.
18. Liang XH, Kleeman LK, Jiang HH, et al: Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72: 8586-8596, 1998.
19. Liang XH, Jackson S, Seaman M, et al: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676, 1999.
20. Qu X, Yu J, Bhagat G, et al: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820, 2003.
21. Scarlatti F, Bauvy C, Ventruti A, et al: Ceramide-mediated macroautophagy involves inhibition of protein kinase B and upregulation of beclin 1. J Biol Chem 279: 18384-18391, 2004.
22. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T and Kuwano H: Inhibition of autophagy by 3MA enhances the effect of 5FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-771, 2009.
23. Sato K, Tsuchihara K, Fujii S, et al: Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 67: 9677-9684, 2007. (Pubitemid 47621214)
24. Paglin S, Lee NY, Nakar C, et al: Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res 65: 11061-11070, 2005.
25. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S and Germano IM: Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 98: 378-384, 2003.